Delivery Order SPE2DE21D7020-SPE2D625F3AWV
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- Boston Scientific Corp has been awarded a delivery order valued at $9,001.72 for agent drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on September 4, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract is funded by the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. Drug-coated balloons are specialized...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- Boston Scientific Corp has been awarded a $48,157.20 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons. The contract, issued on September 8, 2025, carries an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a non-set-aside award, indicating open competition in the federal marketplace, and...
- The Defense Health Agency's Medical Supply Chain awarded Boston Scientific Corp a fixed-price delivery order valued at $7,524.80 for drug-coated balloon medical devices, with an ultimate completion date of August 29, 2025. The contract, which is not set-aside and uses economic price adjustment pricing, will be performed at Boston Scientific's Marlborough, Massachusetts facility. This delivery order represents a discrete procurement under the agency's broader medical device supply chain...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3AWVDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a fixed-price delivery order valued at $17,802.20 to Boston Scientific Corp for agent drug-coated balloons. Issued on September 10, 2025, with an ultimate completion date of September 17, 2025, this delivery order represents a competitive award with no set-aside designation. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes the specialized cardiovascular medical device. Drug-coated balloons are interventional cardiology devices used during percutaneous coronary interventions to treat coronary artery disease, combining mechanical angioplasty with localized drug delivery to reduce restenosis. Boston Scientific, a global leader in medical device manufacturing and innovation, continues to serve as a critical supplier to federal healthcare agencies through numerous delivery orders and indefinite delivery vehicles. The company maintains a robust portfolio of federal contracts with the Defense Health Agency, Veterans Affairs, and Defense Logistics Agency, supplying advanced cardiovascular, interventional, and diagnostic medical technologies. This delivery order exemplifies Boston Scientific's ongoing strategic role in supporting the federal government's medical device procurement needs across multiple healthcare systems and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 9/10/25 |